Note: Ingredients listed on restricted chemical lists
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
*
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
* workplace
General Information
Revision date
2012-03-06
Product name
DEXDOMITOR
Chemical name
Alpha2-adrenoreceptor agonist
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance: Clear, colorless solution
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: May be harmful if swallowed. May be harmful if absorbed through the skin. May cause central nervous system effects. Inhalation of significant quantities of this substance could result in the
Potential health effects
described in 'Known clinical effects' Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on eyes, liver, thymus, endocrine system, and blood and blood forming organs. Known Clinical Effects: May cause decrease in blood pressure (hypotension), sedation, slow breathing, fainting (syncope), and decreased salivation. EU Indication of danger: Not classified Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
